Financing, Equity Capital Markets

Monte Rosa Therapeutics

06/21
|
$255.0 Million
Piper Sandler served as bookrunner for Monte Rosa Therapeutics, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma